Afficher la notice abrégée

dc.contributor.authorMoreno-Sánchez, Inés
dc.contributor.authorAibar-Almazán, Agustín
dc.contributor.authorCarcelén-Fraile, María del Carmen
dc.contributor.authorParra-Díaz, Ana Belén
dc.contributor.authorSánchez-Montesinos García, Indalecio 
dc.contributor.authorSánchez-Alcalá, Marcelina
dc.contributor.authorCano-Sánchez, Javier
dc.contributor.authorHita Contreras, Fidel
dc.date.accessioned2024-10-28T11:15:05Z
dc.date.available2024-10-28T11:15:05Z
dc.date.issued2024-09-25
dc.identifier.citationMoreno Sánchez, I. et. al. Diagnostics 2024, 14, 2123. [https://doi.org/10.3390/diagnostics14192123]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/96393
dc.description.abstract(1) Background: The aim was to analyze the reliability and validity of the Spanish version of the Mini Sarcopenia Risk Assessment (MSRA) in older adults. (2) Methods: A total of 136 participants (72.24 ± 5.21 years, 68.38% women) took part in the study. The MSRA includes two questionnaires with seven (MSRA-7) and five items (MSRA-5). First, reliability (inter-rater and test–retest) of the Spanish MSRA was studied, and then the total scores were compared with the presence of sarcopenia according to three different diagnostic criteria and with other parameters related to sarcopenia (clinical validation). (3) Results: The analysis showed excellent inter-rater and test–retest reliability. As for the clinical validation, and regardless of the criteria, both questionnaires had a high sensitivity (81.82–88.89% for the MSRA-5 and 90.91–94.44% for the MSRA-7), while the MSRA-5 showed a better specificity (32.00–33.90%) than the MSRA-7 (20.80–22.88%). Predictive positive values ranged from 9.57–17.02% (MSRA-5) and 9.17–15.54% (MSRA-7), while predictive negative values were high for both the MSRA-5 (95.24%) and the MSRA-7 (96.30–96.43%). The accuracy was better for the MSRA-5 (36.03–41.18%) than the MSRA-7 (26.47–32.35%), as well as the area under the curve (0.67–0.76 vs. 0.65–0.73, respectively). Higher MSRA-5 and MSRA-7 total scores significantly correlated with greater muscle strength, quantity and gait speed. (4) Conclusions: The adaptation of the Spanish MSRA questionnaires was successfully performed, and they are reliable and clinically valid tools for assessing sarcopenia.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectsarcopeniaes_ES
dc.subjectscreeninges_ES
dc.subjectreliabilityes_ES
dc.titleCross-Cultural Adaptation and Clinical Validation of the Mini Sarcopenia Risk Assessment Questionnaire in Community- Dwelling Spanish Older Adultses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/diagnostics14192123
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional